Gene · 200424
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CircASPH Promotes Hepatocellular Carcinoma Progression Through Methylation and Expression of HAO2. | Front Oncol | 2022 | 35795047 | PubTator, text mining | PubMed |
| Targeted erasure of DNA methylation by TET3 drives adipogenic reprogramming and differentiation. | Nat Metab | 2022 | 35788760 | PubTator, text mining | PubMed |
| Disrupted Alpha-Ketoglutarate Homeostasis: Understanding Kidney Diseases from the View of Metabolism and Beyond. | Diabetes Metab Syndr Obes | 2022 | 35783031 | PubTator, text mining | PubMed |
| Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 35771147 | PubTator, text mining | PubMed |
| An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. | Mol Cell | 2022 | 35764091 | PubTator, text mining | PubMed |
| Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer. | Front Immunol | 2022 | 35757739 | PubTator, text mining | PubMed |
| TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer. | Int J Endocrinol | 2022 | 35755313 | PubTator, text mining | PubMed |
| Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress. | Front Pharmacol | 2022 | 35754474 | PubTator, text mining | PubMed |
| The modulatory effect of high salt on immune cells and related diseases. | Cell Prolif | 2022 | 35747936 | PubTator, text mining | PubMed |
| Discovery and Functional Characterization of Two Regulatory Variants Underlying Lupus Susceptibility at 2p13.1. | Genes (Basel) | 2022 | 35741778 | PubTator, text mining | PubMed |
| Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease. | Biomedicines | 2022 | 35740429 | PubTator, text mining | PubMed |
| Loss of adipose TET proteins enhances β-adrenergic responses and protects against obesity by epigenetic regulation of β3-AR expression. | Proc Natl Acad Sci U S A | 2022 | 35737830 | PubTator, text mining | PubMed |
| The Methylation Game: Epigenetic and Epitranscriptomic Dynamics of 5-Methylcytosine. | Front Cell Dev Biol | 2022 | 35721489 | PubTator, text mining | PubMed |
| DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines. | Cancer Commun (Lond) | 2022 | 35716010 | PubTator, text mining | PubMed |
| A diminished immune response underlies age-related SARS-CoV-2 pathologies. | Cell Rep | 2022 | 35714615 | PubTator, text mining | PubMed |
| Deciphering Obesity-Related Gene Clusters Unearths SOCS3 Immune Infiltrates and 5mC/m6A Modifiers in Ossification of Ligamentum Flavum Pathogenesis. | Front Endocrinol (Lausanne) | 2022 | 35712246 | PubTator, text mining | PubMed |
| Optochemical Control of TET Dioxygenases Enables Kinetic Insights into the Domain-Dependent Interplay of TET1 and MBD1 while Oxidizing and Reading 5-Methylcytosine. | ACS Chem Biol | 2022 | 35709470 | PubTator, text mining | PubMed |
| Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma. | Research (Wash D C) | 2022 | 35707047 | PubTator, text mining | PubMed |
| Mechanisms that regulate the activities of TET proteins. | Cell Mol Life Sci | 2022 | 35705880 | PubTator, text mining | PubMed |
| Rare genetic variants in genes and loci linked to dominant monogenic developmental disorders cause milder related phenotypes in the general population. | Am J Hum Genet | 2022 | 35700724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200424/papers?page=35